Functional magnetic resonance imaging (fMRI) relies on the well-known phenomenon of coupling between neuronal activity and brain blood flow. For nearly a century, the presumption was that hemodynamics were coupled to neuronal activity via energy demand and oxidative metabolism. Early
Introduction
The need for a rigorous reassessment of the ninety-year old, nearly universally accepted hypothesis of Roy and Sherrington (Roy and Sherrington, 1890) -that focal, stimulus-induced increases in brain blood flow are driven by local metabolic demand -was apparent to me by the Spring of 1982. Doing background reading in preparation for what was to be my first series of functional activation experiments, I was struck by the paucity of evidence establishing a chain of causality linking focal, physiological increases in neuronal activity with increases in regional cerebral blood flow (CBF.) Nevertheless, in the pre-PET functional brain mapping literature, the standard practice was to assert that increased neuronal activity was energetically expensive and caused increased metabolic demand that, in turn, upregulated blood flow (e.g. Roland and Larsen, 1976; Roland et al., 1980) . While this was certainly a plausible scenario, it was far from rigorously demonstrated. When I broached this striking lack of evidence for such a widely held belief with Marcus Raichle, my mentor, he agreed, and strongly encouraged me to pursue the issue experimentally.
The prospect of using 15 O tracers and PET for functional brain mapping had brought me to Washington University for a neurology residency in 1980. I majored in liberal arts and philosophy at St. Johns College in Annapolis, focusing my studies on the evolution of epistemology (i.e., the nature of scientific knowledge) from Aristotle to Contents lists available at SciVerse ScienceDirect NeuroImage j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / y n i m g Descartes to Kant. When I applied to medical school, my vision was an academic career studying the neural bases of cognition. As a medical student at Georgetown University, I was fascinated by studies using 133 Xe, single-photon imaging to map language, reasoning, memory and other high-order brain functions (e.g. Larsen et al., 1978; Risberg and Ingvar, 1973; Roland and Larsen, 1976 
The CBF stimulus-rate experiments
Putting my long-term goal of mapping cognitive operations on temporary hold, I focused on the issue of neural-vascular coupling. An ideal experiment to explore the causal link between neuronal activity, metabolic rate and blood would simultaneously measure oxygen metabolism, glucose metabolism, and blood flow over a range of neural response intensities. In 1982, however, this wasn't a possibility. Glucose measurements using 18 FDG were being carried out at a handful of institutions, but this synthesis hadn't been implemented at Washington University. Oxygen metabolic rate (CMRO 2 ) measurements had been implemented several years earlier, using carotid injection of 15 OOlabeled blood (Raichle et al., 1976) , but were deemed too invasive to continue. H 2 15 O CBF measurements were, however, in advanced stages of development and validation . So, H 2
15
O CBF measurements were the place to start.
The next decision points were to select a stimulus modality and develop an experimental design. In the course of an electroencephalography rotation, I came across a pre-market advertising brochure from Grass instruments for a new visual-stimulation system (S10-VS), which consisted of a set of swimming goggles into which circuit boards holding an array of light-emitting diodes had been placed. The system delivered full-field flashes of fixed wavelength, luminance and duration over a range of frequencies from 1 Hz to 128 Hz. Knowing that the time for full recovery of the visual-evoked potential (VEP) was in the range of 125 ms and that H 2 15 O PET measures integrated over a period of 40 s, I reasoned that the CBF response should be linear at least up to a repetition rate of 8 Hz. While not providing insight into the physiological cascade producing the CBF response, at least this experiment would test whether there was a one-to-one relationship between a measure of neural response magnitude (i.e., the number of VEP's elicited during the scanning interval) and the hemodynamic response magnitude. I presented this experimental design to Marcus Raichle, who agreed that it was feasible and would be an important contribution.
Moving forward with this plan, the first obstacle we encountered was trying to obtain a set of the Grass goggles. The S10-VS, it turned out, was not yet available for purchase. The local company representative told me we would simply have to wait until they went into production. This posed a significant problem for me, as my research elective time was already scheduled. Lacking other options, I wrote directly to Mary Grass, the Grass CEO at the time. I explained my circumstances and requested a pre-release version of the goggles. They came by return mail, with no invoice. A gift from Mrs. Grass. This gift, as it turned out, would be put to extraordinarily good use.
I started a 6-month elective block in my 3rd year of residency in January, 1983. Feeling an obligation to be thoroughly versed in all aspects of the PET procedures before recruiting volunteers, I performed my first experimental session on myself (Fig. 1) . As the rate-response experiments were intended to test a hypothesis about hemodynamic physiology, we performed them in a fully quantitative manner. This implied having arterial access, to obtain a time-activity curve of blood tracer concentration. For my self-study, Marcus Raichle placed the arterial and venous catheters. The technicians put on the face mask, placed the Grass goggles over the eye-holes and adjusted the stimulus rates according to my instructions. Peter Herscovitch oversaw the data acquisition.
My self-experiment worked as well as I could have hoped. Robust, well-localized, rate-graded CBF responses were present in visual cortex (Fig. 2) . Confident in the procedures, I performed the same Fig. 1 . The team performing the visual-stimulation, rate-response pilot study is shown. The author (PTF) is in the scanning chair, wearing the Grass S10-VS goggles mounted over the eye-holes of a thermoplastic mask, used for head restraint. A radial arterial catheter is placed in the right wrist and an intravenous catheter is placed in the left anti-cubital fossa. Peter Herscovitch is third from the left. Marcus Raichle is fourth from the right. The scanner is a PETT VI, manufactured by PETT Electronics, a spinoff company created by M. Ter-Pogossian. To analyze, visualize and describe these findings, I developed techniques for global-value normalization, voxel-wise image subtraction and spatial normalization. The spatial normalization methods I developed for these experiments launched the Washington University tradition of reporting activation locations in stereotactic coordinates, a practice which was adopted nearly universally by the brain-mapping community. Once these methods were in place, the data could be analyzed.
The consistency of the responses was impressive. The rate-response function was present in every subject. CBF rose linearly with stimulus rate (r= 0.886; p b 0.0005), reaching a peak value at 8 Hz (Fig. 3a) . Response locations also were tightly grouped, despite the crudeness of the spatial normalization methods. I submitted the manuscript in August, 1983 and it was accepted in October of the same year ; Fig. 3a) . The rate-response function soon was replicated and extended using a reversing checkerboard, constantluminance stimulus . Concurrently, we published a more formal description of the stereotactic method and demonstrated that the responses could be detected equally well in the "raw counts" data, without conversion into physiological units, eliminating the need for arterial catheters in many studies . Based on this work, I received a five-year
Teacher-Investigator Award from the National Institute of Neurological Disorders and Stroke (NS-0904), fulfilling my end of the bargain with William Landau.
In publishing the CBF rate-response data, Marcus Raichle and I emphasized that our results -despite indicating that hemodynamics were tightly coupled to neuronal activity -did not resolve the core question(s) about physiological chain of causality . We noted that "whether a precise coupling exists between neuronal electrical activity and tissue metabolic rate remains a matter of controversy".
The most compelling indications that flow-metabolism uncoupling might exist, in our estimation, were observations in which increased neuronal activity (REM sleep, seizure, etc.) was associated with increased oxyhemoglobin concentration, or rising tissue pO 2 , falling pCO 2 , and rising pH (Leniger-Follert, 1984; Leniger-Follert and Hossmann, 1979; Santiago et al., 1984; Urbanics et al., 1978) . Wilder Penfield, for example, reported regional hyperemia and hyperoxia during focal seizures observed intra-operatively (Penfield, 1971) . Sidney Goldring, then Chief of Neurosurgery at Washington University, agreed with Penfield's observations and provided me with photographs of the effect (Fig. 4) . I considered this fairly compelling evidence that CBF:CMRO 2 uncoupling occurred, at least under some neuronal-activation conditions, and was anxious to more forward with more definitive experiments.
The CBF:CMRO 2 experiments
At the same time that our initial CBF rate-effect experiment was being performed and published, Mark Mintun, Marcus Raichle and colleagues were developing and validating (by comparison to a stochastic wash-out method in baboons) the "three-step method" for CMRO 2 . This now-classic approach uses sequential administration of three . From these three explicit measurements and measurement of blood pO 2 (via arterial catheter), absolute CMRO 2 can be computed. While time consuming and labor intensive, the method is undeniably rigorous and thoroughly validated, far more so than any subsequent CMRO 2 method developed for PET or fMRI. Once these PET . Panel B shows the rate-response functions obtained by inversion recovery (IR; flow weighted) and gradient echo (GE; oxygenation weighted) BOLD fMRI overlaid on the PET response function (Kwong et al., 1992) .
Fig. 4.
The image is intra-operative photograph (courtesy of Sidney Goldring) of an epileptogenic lesion (an arteriovenous malformation) abutting the primary motor cortex mouth region. Circumscribed hyperemia and hyperoxia is seen under "ticket" 20, during a focal motor seizure of the mouth region. The phenomenon of seizureinduced hyperemia/hyperoxia was described by Wilder Penfield (Penfield, 1971 ).
Other authors (Leniger-Follert, 1984) reported similar findings in other preparations.
methods were in place and validated, we were ready to measure CBF and CMRO 2 during functional activation.
Expecting that some degree of uncoupling was likely to be observed, we debated the best experimental design. Should we explore the rate effect using the Grass goggles? Or should we explore a stimulusduration effect? We presumed from prior literature (above), that the uncoupling effect would have rapid onset; we weren't sure how long it might persist. We opted to pursue a duration effect, with stimulus durations of zero, 1 and 5 min prior to tracer delivery. Feeling that staring into the Grass goggles flashing at 8 Hz for 5 min would be unpleasant, I looked for alternatives. I spent a considerable amount of time reading the works of Vernon Mountcastle and others in the area of somatosensory stimulation, learning that vibrotactile stimulation can entrain cortical neurons at rates exceeding 200 Hz. A few preliminary H 2 15 O CBF studies confirmed that the response to finger-pad vibration was robust, non-fatiguing and readily tolerated. So, the choice was made to move forward with Mintun's three-step-method experiment using vibrotactile stimulation.
Even for resting-state measures,
15
O CBF:CMRO 2 experiments are complex and time consuming, as three different radiotracers are administered while drawing arterial samples as rapidly as possible. To allow for radiotracer decay (T 1/2 = 123 s), tracers are administered at intervals of no shorter than 10 min. Acquiring four different scan conditions (rest, 0 min, 1 min, and 5 min) for each of three different tracers takes a minimum of 3 h. Placing the arterial and venous lines, immobilizing the head and performing the transmission scans adds another hour to the session. For each of nine subjects, I placed the arterial and venous lines, administered the radiotracers, oversaw data acquisition and reconstruction, and analyzed all the data. To ensure inter-subject procedural consistency, all the experiments were obtained over a period of a few months. There were fully analyzed by the Fall of 1984. The results were much as we had suspected.
CBF, reliable as ever, rose robustly in every subject. CBV shadowed CBF: lower in magnitude, but just as consistent. CMRO 2 rose weakly (8%), not reaching statistical significance. The OEF response, on the other hand, was absolutely unequivocal. OEF fell by a highly significant 19%, conclusively demonstrating that the blood flow increase far exceeded the oxygen demand. When performed using arterial sampling, PET provides absolute measures in physiological units (not just relative measurements as percent change). Because we obtained all data in a "fully quantitative" mode, we confirmed that CBF and CMRO 2 were highly correlated at rest despite being uncorrelated during task. This motivated our description of the effect as "uncoupling". These results clearly contradicted the Roy and Sherrington postulate. They also contradicted a single-subject report that Marcus had published (Raichle et al., 1976) , using the carotid-injection method. Nevertheless, the data were scrupulously acquired and analyzed; they needed to be presented to the community. When I reviewed these data with Marcus, he encouraged me to submit them for the XII meeting of the International Society of Cerebral Blood Flow and Metabolism (ISCBF&M), to be held in Ronneby-Lund, Sweden in June, 1985.
Ronneby-Lund
Auspicious signs: my abstract was assigned an oral presentation; I received a Scanditronix Travel Fellowship (one of two). The Scanditronix fellowship not only paid my way to Ronneby, it also funded a visit to Stockholm after the meeting. I was thrilled. This was my first trip outside the United States and my first presentation to an international audience. Before leaving Saint Louis, I gave my talk to the entire laboratory, getting practice fielding aggressive questions. The border control officer at Kastrup Airport gave my virgin passport its first stamp. In Ronneby, the night before my presentation, I rehearsed my talk repeatedly with Joel Perlmutter, a fellow former resident also working in Raichle's laboratory. Joel asked and re-asked every question he could think of until my replies were crisp and compelling. This was enormously helpful. I felt ready.
My talk was toward the end of the second morning session. The meeting room was large and packed, as there were no parallel sessions at ISCBF&M. My talk proceeded smoothly as I presented the methods. When I moved onto the results, however, I was interrupted by shouts of disagreement (not questions or comments) from the audience. One person stood up and shouted that I overestimated my CBV correction. I paused, then continued. When the moderator opened the talk for questions, they came in a torrent. Some were complimentary but skeptical. Others were uncomplimentary and openly critical. I responded to each, providing well-rehearsed explanations, but did not win over my audience. The questions and comments continued at length, well beyond the time allotted for my talk and into that of the next two speakers. Not wishing to interrupt the dialog, the moderator allowed this to continue until the end of the session. The two skipped talks from the morning session opened the afternoon session.
The end of the session didn't end the barrage of criticism. For the rest of the meeting, my conversations were monopolized by the aftermath of my presentation. Walking to lunch, eating lunch, over drinks, over dinner: everyone wanted to question, to criticize, to register incredulity. The harshest comments were that I was scientifically irresponsible and had no business presenting such controversial nonsense in this international venue. I know that Raichle received much the same treatment. Louis Sokoloff, inventor of the FDG method, wasn't shy about expressing his disapproval. In questioning metabolism as the mediator of flow, we seriously undermined the importance of the FDG method, long touted as the most direct imaging index of neuronal activity. Neither Raichle nor I, however, backed off of our findings. We knew that we had done our best and we knew what we had observed.
Returning from Sweden, Raichle wanted to be absolutely certain of our results before taking them to a peer-reviewed publication. The most telling criticism we had encountered was the possibility that the effects we were observing were transient (i.e., not steady state), despite the fact that we had demonstrated stability out to 5 min. Another was that the effect might be somatosensory-system specific. To address these, I carried stimulation out to 45 min in a small group of subjects. Same result. I also did some visual-stimulus and hand-movement trials. Same result. With these data in hand, I was given the green light to submit the data to PNAS in October, four months after my presentation in Sweden.
The reviews returned quickly. The reviewers' responses were overwhelmingly positive and complimentary, despite the lambasting I had received in Ronneby. The work was considered "excellent", "revolutionary", with "unexpected results and bold conclusions" which "will open new avenues and greatly stimulate future research…". It was accepted with minor revisions and published in February . At the time of writing, this manuscript has more than 1000 citations.
The CBF:CMRO 2 :CMRgluc experiments
In pondering the neuronal-hemodynamic-metabolic coupling puzzle, glucose metabolism was the piece hardest to fit into place. O "gold-standard" of withinsubject, within-session, task-control contrasts and voxel-wise subtractions hadn't been achieved. From our perspective, therefore, the 18 FDG literature was inconclusive and we pointedly commented on this in the discussion section of the somatosensory CBF:CMRO 2 paper . The obvious next step was to "up the ante" and perform within-subject comparisons of CBF with CMRO 2 , and CMRgluc.
The experimental design we adopted was paired measurement of CBF and CMRO 2 in one group of subjects (n = 5) and paired measurement of CBF and CMRgluc in a second group of subjects (n = 5). Because of the long T 1/2 of 18 F, we waited an hour after completion of the first 18 FDG scan (~2 h after the first injection) before giving the second injection, and included a pre-scan to correct for residual tracer. For this series of experiments, we returned to the visual system. In collaboration with David Van Essen and John Allman, we had developed a constant-luminance, annular checkerboard stimulus for retinotopy studies (Fox et al., , 1987 . Delivered with a large, high-speed monitor, this system provided activation responses even more robust and more extensive than those obtained with the Grass S10-VS. As anticipated, we saw highly significant CBF responses in each of the 10 subjects (Fig. 5) . The average response in each subject group was 49-50%. As previously, CMRO 2 showed only a weak increase (mean = 5%). For the first time, we were able to demonstrate that the CMRO 2 changes were statistically significant, but only by pooling data with our prior experiments. CMRgluc responses (51% mean) closely matched the CBF responses. At rest, CMRO 2 and CMRgluc were closely coupled, with a stoichiometric ratio of 4.1, closely matching previously reported values. During task, however, the CMRgluc increase was 10 fold greater than the CMRO 2 increases. Clearly, the CMRgluc increases were not for the sake of the oxidative metabolism and probably not for ATP production, as had been assumed since the development of the FDG method. Rather, the hemodynamic and metabolic physiology associated with neuronal responses was far more complicated than anyone had expected.
These results were submitted to Science in March, 1988 and accepted in May (Fox et al., 1988) . As with our PNAS submission, the reviewers' comments were highly complimentary, encouraging us to be bold in our conclusions. Regarding flow and metabolism coupling, we broadly concluded, "traditional concepts of the dynamic regulation of cerebral metabolism and blood flow must be reconsidered".
And,
"blood flow increases during neural activity are regulated by a mechanism, and serve a need, other than oxidative metabolism."
At a more specific level, we speculated that the disproportionate increase in CMRgluc (over CMRO 2 ) might indicate a shift in metabolic pathway, from glucose oxidation to glycolysis. If so, this would be associated with an increase in tissue lactate. As a possible cause for such a pathway shift, we drew attention to prior evidence that the brain might be near it's enzymatic capacity (of cytochrome oxidase) and unable to up-regulate respiration. Because of the clear surfeit of oxygen, we did not entertain the prospect of oxygen lack as being a viable mechanistic option.
In 1989, I accepted a position at the Mind-Brain Institute at Johns Hopkins University, ending my participation in the Washington University contributions to the "coupling controversy". My nine-years of training at Washington University had been enormously productive. I consider this a testimony to Ter-Pogossian's vision of the versatility of 15 O cornerstone for a PET research program and to the outstanding research environment provided by Ter-Pogossian, Raichle and the researchers they attracted to their laboratory. It was an honor to have worked with them.
The traveling goggles
Activation responses to the Grass goggles were remarkably reliable. So much so, that when Jack Belliveau called me to describe a new, contrast-enhanced magnetic resonance imaging (MRI) method for measuring cerebral blood volume (CBV) and asked for advice regarding stimulus selection, I told him that the Grass goggles were his best option. Being constructed of plastic and LED's, I was confident they would be MRI compatible. Jack agreed and I shipped the goggles to Boston. Thereafter, I got periodic calls from Jack with progress updates and questions. The most memorable questions were how to correct for spatial-resolution-based magnitude differences between PET and fMRI and what were the expected proportionalities of CBF and CBV during activation. In 1991, Jack's project appeared on the cover of Science, in the now-classic paper introducing fMRI to an appreciative world (Belliveau et al., 1991) . While I was disappointed not to be offered co-authorship, Jack won my undying gratitude by reporting his results in stereotactic coordinates. This established a precedent that fMRI researchers adopt the reporting standards used in the PET community, rather than creating their own. Well satisfied with the performance of the Grass goggles, Jack passed them on to Ken Kwong for use in the MGH's next stage of fMRI developments. Advised by Marcus Raichle, Segi Ogawa and the Minnesota group also purchased a set of Grass goggles for use in their inaugural fMRI experiments. One enormously enjoyable side effect of our controversial (and generally stressful) role in challenging the status quo was that it provided Marcus and myself ring-side seats for a dramatic, head-to-head competition between the world's leading MR groups to replicate -or disprove -our findings.
The BOLD experiments
The first magnetic resonance test of our controversial "uncoupling" results came from Yale. Motivating his report by reference to our recent Science paper, James Prichard used Grass S10-VS goggles and 1 H magnetic resonance spectroscopy (MRS) to measure brain lactate during physiological stimulation (Prichard et al., 1991) . As predicted, he found "lactate elevation occurs in the course of normal brain function, most probably due to a transient excess of glycolysis over respiration".
In 1992 the first descriptions of BOLD fMRI appeared in the literature. Three groups were in close competition: the MGH group, with Kenneth Kwong as lead author (Kwong et al., 1992) ; the University of Minnesota group, with Segi Ogawa as lead author (Ogawa et al., 1992) ; and the University of Wisconsin group, with Peter Bandettini as lead author (Bandettini et al., 1992) . For all three groups, our CBF:CMRO 2 PET results provided motivation for the developments, or an interpretive framework for the results, or both. Segi Ogawa (Ogawa et al., 1992) framed his group's interest in BOLD contrast by stating:
"positron emission tomography imaging experiments demonstrate stimulation-produced increases in regional cerebral blood flow without significantly changing local oxygen use, thus predicting an elevation in venous-blood oxygenation. This result suggested that BOLD contrast imaging could be used to map human mental operations".
Ogawa interpreted their results saying:
"the changes are caused by a stimulus-induced change in magnetic susceptibility that results from a reduced concentration of the paramagnetic species deoxyhemoglobin in venous blood. This interpretation is consistent with positron emission tomography experiments that show a large increase in regional blood flow and little increase in oxygen utilization, thus predicting a localized increase in venous blood oxygenation".
Choosing an experimental paradigm we had considered for our CMRO 2 studies but not selected, Kwong extended our CBF rateresponse observations to fMRI. In doing so, he precisely replicated the rate-response function we described previously Raichle, 1984, 1985) , using both a CBF-weighted inversion recovery (IR) pulse sequence and an oxygenation-weighted gradient echo (GE) pulse sequence (Fig. 3b) . From these, Kwong concluded:
"Our results independently confirm PET observations that activationinduced changes in blood flow and volume area accompanied by little or no increase in tissue oxygen consumption."
Needless to say, I was extremely gratified by these developments. I was pleased both that my prior work had motivated the development of such a novel imaging technique and pleased that the results so clearly confirmed our PET observations. Further, both Ogawa and Bandettini extended the "uncoupling" phenomenon to the motor system, putting another nail in the coffin of the argument that it was a system-specific effect. From this point forward, every time a BOLD paper reported brain activation in a new region, the generality of the uncoupling effect was confirmed and extended.
Emerging physiological models
Having demonstrated that fMRI could detect both task-driven changes in hemodynamics and hemodynamic-metabolic dissociation, physiological models to quantify CMRO 2 and OEF using fMRI seemed tantalizingly close. Essential components of any such models, however, were the mathematical relationships posited between hemodynamics (CBF and CBV) and metabolism (CMRO 2 ) and, more fundamentally, the physiology upon which the mathematics were based. Conceptualizations of the physiology, however, were very much in flux. Our observation (with Prichard's confirmation) that CMRO 2 and CMRgluc were dissociated argued in favor of the "enzymatic limitation" hypothesis, with metabolic pathway shifting from oxidative (rest) to glycolytic (task). An alternative hypothesis was that, despite the evident vascular hyperoxia during task, brain tissue might experience an oxygen debt, at least transiently, due to oxygen-diffusion limitation from the blood vessel to the active neurons. Addressing this issue, Malonek and Grinvald (1996) employed intrinsic-signal optical imaging to demonstrate brief, highly focal tissue hypoxia, followed by longer-lasting, more extensive hyperoxia. From this, they suggested that O 2 demand might still be the factor driving CBF increases, with the brain's vasculature "watering the entire garden for the sake of one thirsty flower". Shortly thereafter, Science ran a review article re-addressing the "coupling controversy" at the tenyear anniversary of our 1988 Science paper (Barinaga, 1997) . Interviewing many of the leading investigators in the field, she drew the conclusion that community consensus had now swung the other way.
The "thirsty flower" theory informed several models for computing CMRO 2 %Δ from fMRI (Buxton and Frank, 1997; Hoge et al., 1999; Hyder et al., 1998) . Unfortunately, all of these models produced CMRO 2 %Δ values substantially greater (several fold higher) than those obtained by PET. In response, Mark Mintun (Mintun et al., 2001) performed CBF activation experiments under conditions of hypoxia. These confirmed that tissue hypoxia (i.e., increased O 2 debt) did not enhance the CBF response. Mintun concluded that "thirsty flower" hypothesis was untenable and specifically criticized the underlying assumptions made by the fMRI models. Mintun extended this by demonstrating that the lactate/pyruvate ratio, on the other hand, did augment the CBF response, suggesting a key role of glycolysis in CBF regulation (Mintun et al., 2004) . Despite completely undermining the central assumptions of the fMRI modeling methods, these papers were largely ignored by the fMRI community. From my seat on the sidelines, active participants in the coupling controversy appeared divided into the PET users and the fMRI users, each harboring deep suspicions about the other's methods and models. In the PET community, the fMRI models were regarded as unvalidated (in contrast to Mintun's rigorous validation of the 15 O PET method), incapable of measuring absolute values (i.e., only making % change measurements), and heavily dependent upon assumed parameters, including the coupling ratio. In the MRI community, the PET models were looked upon as likely too complex and too slow (requiring three measurements spaced by 10 min) to be physiologically reliable, despite the paucity of assumed parameters.
The Lin-Gao papers: a resolution
In 1991, I accepted my current position, as Director of the Research Imaging Institute (RII) at the University of Texas Health Science Center in San Antonio. My move was motivated by a desire to have unimpeded access to both 15 O PET and MRI, something that I was unable to secure at Johns Hopkins. One of my first recruits to the new institute was Jia-Hong Gao, an expert in quantitative CBF measurements using MRI. Gao's recruitment reflected my belief that the future of studies in this area needed to be shaped by a group that was equally versed in both methods. As the coupling controversy evolved, Jia-Hong and I agreed that the only way to move forward was to bring the two imaging modalities into agreement. Physiologically, there was only one truth. If the modalities couldn't agree, the problem was with the methodologists. Still more pragmatically, if we hoped to combine the respective advantages of PET and fMRI to study hemodynamic and metabolic (e.g., mitochondrial) disorders, they needed to be in agreement.
Working under Jia-Hong and myself as co-mentors, a series of pre-doctoral students in our Medical Physics program attacked this problem, but without making significant headway. The impasse finally began to be breached when Ai-Ling Lin entered our program in 2002. Ai-Ling's strategy was relatively simple: apply accepted fMRI methods but make as few assumptions as possible and measure every possible parameter (Lin et al., 2008 (Lin et al., , 2009 . Rather than assume a fixed relationship between CBF and CBV, measure both. Rather than take the parameters from literature as reliable, Ai-Ling re-visited the accuracy of the basal BOLD relaxation rate (M) determination used in prior models. This approach worked. PET and MRI measurements of CBF and CMRO 2 could be brought into agreement. In presenting these data to the MRI community, Ai-Ling was subjected to much the same brusque treatment I had received in Ronneby-Lund. (The imaging community does like to watch fights.) While this gave me some pangs of guilt, I was thrilled at the outcome. PET and fMRI were finally in agreement, and our original "uncoupling" papers again proven correct (Lin et al., 2010) .
To interpret her findings, however, Ai-Ling turned away from both of the previously dominant theories (enzymatic capacity and oxygen debt) regarding CBF control. Instead, she looked to a much more complex model: the astrocyte-neuron lactate shuttle (ANLS) model of Pellerin and Magistretti (1994) . By the ANLS model, oxygen consumption is predominantly neuronal, while glia preferentially consume glucose. Further, the bulk of the glucose consumed during neuronal activation is for the sake of glutamate, an excitatory neurotransmitter. By the ANLS model, task-induced increases in neuronal activity have minimal energy demands. CBF up-regulation is chiefly driven by the lactate generated by in the course of glutamate shuttling. As judged by citations and review articles, community consensus now favors complex, multi-factorial explanations of the underlying physiology and that "neurotransmitters, particularly glutamate, rather than energy use are the principal agents generating activity-induced blood flow..." (Attwell et al., 2010) . How long this theory will prevail remains to be seen. In any event, the prediction of the reviewer of our original "uncoupling paper", that our paper "will open new avenues and greatly stimulate future research…", proved prescient. The 15 O PET "uncoupling" studies provided a substantial impetus to the field of neuroimaging, driving the development of new imaging methods and promoting a much deeper understanding of the underlying physiology.
